DEXCOM, INC. Treasury Stock, Value, Acquired, Cost Method
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- DEXCOM, INC. treasury stock, value, acquired, cost method for the quarter ending 2026-06-30 was $605.60M.
- DEXCOM, INC. treasury stock, value, acquired, cost method for the quarter ending 2025-12-31 was $315.90M.
- DEXCOM, INC. treasury stock, value, acquired, cost method for the quarter ending 2025-09-30 was $187.70M, a 74.96% decline year-over-year.
- DEXCOM, INC. treasury stock, value, acquired, cost method for the quarter ending 2024-12-31 was $0.00.
- DEXCOM, INC. treasury stock, value, acquired, cost method for fiscal 2025 was $503.60M, a 32.81% decline from fiscal 2024.
- DEXCOM, INC. treasury stock, value, acquired, cost method for fiscal 2024 was $749.50M, a 8.75% increase from fiscal 2023.
- DEXCOM, INC. treasury stock, value, acquired, cost method for fiscal 2023 was $689.20M, a 23.58% increase from fiscal 2022.
- DEXCOM, INC. treasury stock, value, acquired, cost method for fiscal 2022 was $557.70M.
| Period end | Treasury Stock, Value, Acquired, Cost Method 3 month | Treasury Stock, Value, Acquired, Cost Method 12 month |
|---|---|---|
| 2026-06-30 | $605.60M 10-Q · filed 2026-07-30 | |
| 2025-12-31 | $315.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $503.60M 10-K · filed 2026-02-12 |
| 2025-09-30 | $187.70M 10-Q · filed 2025-10-30 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $749.50M 10-K · filed 2026-02-12 |
| 2024-09-30 | $749.50M 10-Q · filed 2025-10-30 | |
| 2023-12-31 | $689.20M 10-K · filed 2026-02-12 | |
| 2023-06-30 | $189.10M 10-Q · filed 2024-07-25 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $557.70M 10-K · filed 2025-02-18 |
| 2022-09-30 | $557.70M 10-Q · filed 2023-10-26 | |
| 2018-12-31 | $100.00M 10-K · filed 2021-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |